296 studies found for:    "Genital Diseases, Female" | Canada
Show Display Options
Rank Status Study
1 Completed Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women
Conditions: Dysmenorrhea;   Dyspareunia;   Endometriosis;   Pelvic Pain
Intervention: Drug: ERB-041
2 Completed Safety and Efficacy Clinical Study of SNS-595 in Patients With Platinum-Resistant Ovarian Cancer
Condition: Epithelial Ovarian Cancer
Intervention: Drug: Voreloxin Injection
3 Recruiting TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cancer
Interventions: Drug: AMG 386;   Drug: Paclitaxel;   Drug: AMG 386 Placebo;   Drug: Carboplatin
4 Completed Radiation Therapy or Observation Only in Treating Patients With Endometrial Cancer Who Have Undergone Surgery
Condition: Endometrial Cancer
Intervention: Radiation: radiation therapy
5 Completed
Has Results
An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Trabectedin;   Drug: DOXIL;   Drug: Dexamethasone
6 Completed A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial Cancer
Conditions: Ovarian Cancer;   Endometrial Cancer
Intervention: Drug: MKC-1
7 Completed Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors
Conditions: Childhood Germ Cell Tumor;   Drug/Agent Toxicity by Tissue/Organ;   Extragonadal Germ Cell Tumor;   Ovarian Cancer
Interventions: Biological: bleomycin sulfate;   Drug: amifostine trihydrate;   Drug: cisplatin;   Drug: etoposide;   Procedure: conventional surgery
8 Completed
Has Results
Somatropin Treatment to Final Height in Turner Syndrome
Condition: Turner Syndrome
Interventions: Drug: Somatropin;   Drug: Ethinyl estradiol;   Drug: Medroxyprogesterone acetate
9 Recruiting A Study of Rucaparib as Switch Maintenance Following Platinum-Based Chemotherapy in Patients With Platinum-Sensitive, High-Grade Serous or Endometrioid Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer;   Peritoneal Cancer
Interventions: Drug: Rucaparib;   Drug: Placebo
10 Completed
Has Results
AZD0530 Phase II Study in Patients With Advanced Ovarian Cancer
Conditions: Ovarian Neoplasms;   Ovarian Cancer
Interventions: Drug: AZD0530;   Drug: Carboplatin;   Drug: Paclitaxel
11 Completed
Has Results
A Study of Ixabepilone as Second-line Therapy for Locally Advanced, Recurrent, or Metastatic Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Drug: Ixabepilone;   Drug: Doxorubicin;   Drug: Paclitaxel
12 Active, not recruiting LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer
Conditions: Ovarian Neoplasms;   Peritoneal Neoplasms
Interventions: Drug: Placebo;   Drug: BIBF 1120
13 Active, not recruiting Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Stage IB Cervical Cancer;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Cervical Cancer;   Stage IVA Cervical Cancer
Interventions: Drug: cisplatin;   Drug: tirapazamine
14 Active, not recruiting Sunitinib in Treating Patients With Recurrent or Metastatic Endometrial Cancer
Conditions: Endometrial Adenocarcinoma;   Endometrial Papillary Serous Carcinoma;   Recurrent Endometrial Carcinoma;   Recurrent Uterine Sarcoma;   Stage IV Endometrial Carcinoma;   Stage IV Uterine Sarcoma;   Uterine Carcinosarcoma
Intervention: Drug: sunitinib malate
15 Recruiting A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Condition: Endometriosis
Interventions: Drug: Elagolix;   Other: placebo
16 Recruiting Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)
Conditions: Heavy Uterine Bleeding;   Uterine Fibroids
Interventions: Other: Placebo;   Drug: Elagolix;   Drug: Estradiol/norethindrone acetate, E2/NETA;   Drug: Estradiol/norethindrone acetate, E2/NETA Dose 2;   Drug: Estradiol/norethindrone acetate
17 Recruiting A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: bevacizumab [Avastin];   Drug: carboplatin;   Drug: Paclitaxel
18 Unknown  Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Primary Peritoneal Cavity Cancer
Intervention: Biological: oregovomab
19 Completed Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Primary Peritoneal Cavity Cancer
Interventions: Drug: carboplatin;   Drug: epirubicin hydrochloride;   Drug: paclitaxel;   Procedure: conventional surgery
20 Active, not recruiting Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
Conditions: Fallopian Tube Cancer;   Female Reproductive Cancer;   Ovarian Carcinosarcoma;   Ovarian Sarcoma;   Recurrent Ovarian Epithelial Cancer;   Recurrent Uterine Sarcoma;   Stage III Ovarian Epithelial Cancer;   Stage III Uterine Sarcoma;   Stage IV Ovarian Epithelial Cancer;   Stage IV Uterine Sarcoma;   Uterine Carcinosarcoma;   Uterine Leiomyosarcoma
Interventions: Drug: ziv-aflibercept;   Other: laboratory biomarker analysis;   Other: pharmacological study

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years